These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16374309)
1. Strategies for success in drug development. Wardell WM Retina; 2005 Dec; 25(8 Suppl):S100-S102. PubMed ID: 16374309 [No Abstract] [Full Text] [Related]
2. Use of high-content analysis for compound screening and target selection. Rausch O IDrugs; 2005 Jul; 8(7):573-7. PubMed ID: 15973566 [TBL] [Abstract][Full Text] [Related]
3. Drug discovery: Chemical beauty contest. Leeson P Nature; 2012 Jan; 481(7382):455-6. PubMed ID: 22281594 [No Abstract] [Full Text] [Related]
4. Celebrating the SSCI: the drug discovery pathway: challenges and pitfalls. Bennett JC Am J Med Sci; 2003 Dec; 326(6):329-32. PubMed ID: 14671495 [No Abstract] [Full Text] [Related]
5. [From molecule to medicine--drug development]. Bruhn C Dtsch Med Wochenschr; 2010 Feb; 135(6):p5. PubMed ID: 20151355 [No Abstract] [Full Text] [Related]
7. Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered. Lee LS; Nafziger AN; Bertino JS Clin Pharmacol Ther; 2005 Jul; 78(1):1-6. PubMed ID: 16003286 [No Abstract] [Full Text] [Related]
8. Scaffold composition and biological relevance of screening libraries. Shelat AA; Guy RK Nat Chem Biol; 2007 Aug; 3(8):442-6. PubMed ID: 17637770 [TBL] [Abstract][Full Text] [Related]
9. Fragment-based lead discovery. Rees DC; Congreve M; Murray CW; Carr R Nat Rev Drug Discov; 2004 Aug; 3(8):660-72. PubMed ID: 15286733 [No Abstract] [Full Text] [Related]
10. Safety and efficacy: the role of chemistry, manufacturing, and controls in pharmaceutical drug development. DiFeo TJ Drug Dev Ind Pharm; 2004 Mar; 30(3):247-57. PubMed ID: 15109024 [No Abstract] [Full Text] [Related]
11. Improved early clinical development through human microdosing studies. Wilding IR; Bell JA Drug Discov Today; 2005 Jul; 10(13):890-4. PubMed ID: 15993808 [No Abstract] [Full Text] [Related]
12. Strategic use of preparative chiral chromatography for the synthesis of a preclinical pharmaceutical candidate. Leonard WR; Henderson DW; Miller RA; Spencer GA; Sudah OS; Biba M; Welch CJ Chirality; 2007 Sep; 19(9):693-700. PubMed ID: 17354260 [TBL] [Abstract][Full Text] [Related]
14. Introduction of the high throughput screening system. Li Y Chin Med Sci J; 2001 Sep; 16(3):179-81. PubMed ID: 12899335 [TBL] [Abstract][Full Text] [Related]
15. High-throughput screening assays for the identification of chemical probes. Inglese J; Johnson RL; Simeonov A; Xia M; Zheng W; Austin CP; Auld DS Nat Chem Biol; 2007 Aug; 3(8):466-79. PubMed ID: 17637779 [TBL] [Abstract][Full Text] [Related]
16. Less is more: the human microdosing concept. Garner RC Drug Discov Today; 2005 Apr; 10(7):449-51. PubMed ID: 15809185 [No Abstract] [Full Text] [Related]
17. Drug Discovery Technology Europe 2007--An Informa Conference. Better tools for early decision-making. 12-15 March 2007, London, UK. Terrett N IDrugs; 2007 May; 10(5):320-3. PubMed ID: 17487783 [No Abstract] [Full Text] [Related]